No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NVCR240621P25000
- 5.50
- 0.000.00%
15min DelayClose Jun 18 15:59 ET
0.00High0.00Low
5.50Open5.50Pre Close0 Volume928 Open Interest25.00Strike Price0.00Turnover0.00%IV-0.31%PremiumJun 21, 2024Expiry Date5.56Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.50Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Novocure(NVCR.US) Director Sells US$23,032.85 in Common Stock
$Novocure(NVCR.US)$ Director VERNON W ANTHONY sold 964 shares of common stock on Jun 4, 2024 at an average price of $23.893 for a total value of $23,032.85.Source: Announcement What is statement of ch
Novocure(NVCR.US) Director Sells US$23,025.24 in Common Stock
$Novocure(NVCR.US)$ Director LEUNG GABRIEL sold 964 shares of common stock on Jun 4, 2024 at an average price of $23.8851 for a total value of $23,025.24.Source: Announcement What is statement of chan
Novocure(NVCR.US) Director Sells US$23,027.45 in Common Stock
$Novocure(NVCR.US)$ Director Scannell Timothy J sold 964 shares of common stock on Jun 4, 2024 at an average price of $23.8874 for a total value of $23,027.45.Source: Announcement What is statement of
A Closer Look at 7 Analyst Recommendations For NovoCure
7 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings,
Comments
$Novocure(NVCR.US$ pt anyone?
2
$Novocure(NVCR.US$ I placed limit buy @13.1 but got filled at 13.299, I noticed this many times in this app, they are causing slippage, anyone noticed same?
1
$iBio Inc (IBIO.US)$ IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for obesity and cardiometabolic diseases.
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
Morning Movers
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
34
Key Takeaway
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
1
Read more
灵巧的托拜厄斯 : having
Kenneil NugentOP : lol no help